TWD 94.5
(1.07%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 498.01 Million TWD | 26.33% |
2022 | 420.51 Million TWD | -5.0% |
2021 | 442.63 Million TWD | 2.0% |
2020 | 433.95 Million TWD | -20.32% |
2019 | 544.6 Million TWD | 114.68% |
2018 | 253.68 Million TWD | -17.16% |
2017 | 306.24 Million TWD | -24.61% |
2016 | 406.22 Million TWD | 1.43% |
2015 | 400.5 Million TWD | 11.24% |
2014 | 360.05 Million TWD | 0.52% |
2013 | 358.18 Million TWD | -7.05% |
2012 | 385.35 Million TWD | 7.72% |
2011 | 357.75 Million TWD | -0.94% |
2010 | 361.14 Million TWD | 19.94% |
2009 | 301.09 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 124.45 Million TWD | -8.86% |
2024 Q1 | 136.55 Million TWD | 47.51% |
2023 FY | 531.22 Million TWD | 26.33% |
2023 Q4 | 92.57 Million TWD | -40.75% |
2023 Q3 | 156.23 Million TWD | 12.77% |
2023 Q2 | 138.54 Million TWD | -3.7% |
2023 Q1 | 143.86 Million TWD | 11.01% |
2022 Q2 | 75.99 Million TWD | 5.2% |
2022 Q4 | 129.6 Million TWD | -9.16% |
2022 FY | 420.51 Million TWD | -5.0% |
2022 Q1 | 72.23 Million TWD | 38.03% |
2022 Q3 | 142.67 Million TWD | 87.74% |
2021 Q1 | 114.59 Million TWD | -0.32% |
2021 Q3 | 66.83 Million TWD | -12.92% |
2021 Q4 | 52.33 Million TWD | -21.69% |
2021 FY | 442.63 Million TWD | 2.0% |
2021 Q2 | 76.74 Million TWD | -33.03% |
2020 Q1 | 74.8 Million TWD | 22.96% |
2020 Q4 | 114.95 Million TWD | 2.41% |
2020 Q3 | 112.24 Million TWD | -19.19% |
2020 FY | 433.95 Million TWD | -20.32% |
2020 Q2 | 138.9 Million TWD | 85.68% |
2019 Q2 | 106.95 Million TWD | 42.0% |
2019 Q4 | 60.83 Million TWD | -41.59% |
2019 FY | 544.6 Million TWD | 114.68% |
2019 Q1 | 75.32 Million TWD | 16.19% |
2019 Q3 | 104.16 Million TWD | -2.62% |
2018 FY | 253.68 Million TWD | -17.16% |
2018 Q4 | 64.82 Million TWD | -24.54% |
2018 Q3 | 85.9 Million TWD | 68.6% |
2018 Q2 | 50.95 Million TWD | -2.0% |
2018 Q1 | 51.99 Million TWD | -3.81% |
2017 Q4 | 54.05 Million TWD | -39.37% |
2017 FY | 306.24 Million TWD | -24.61% |
2017 Q2 | 76.61 Million TWD | -11.34% |
2017 Q1 | 86.42 Million TWD | 32.81% |
2017 Q3 | 89.15 Million TWD | 16.36% |
2016 Q2 | 114.35 Million TWD | -9.05% |
2016 Q3 | 101.07 Million TWD | -11.61% |
2016 FY | 406.22 Million TWD | 1.43% |
2016 Q4 | 65.06 Million TWD | -35.62% |
2016 Q1 | 125.72 Million TWD | -1.38% |
2015 Q3 | 112.62 Million TWD | 51.46% |
2015 FY | 400.5 Million TWD | 11.24% |
2015 Q1 | 86.03 Million TWD | -17.83% |
2015 Q4 | 127.48 Million TWD | 13.19% |
2015 Q2 | 74.36 Million TWD | -13.57% |
2014 Q1 | 85.91 Million TWD | 8.97% |
2014 Q3 | 83.14 Million TWD | -3.65% |
2014 FY | 360.05 Million TWD | 0.52% |
2014 Q4 | 104.7 Million TWD | 25.93% |
2014 Q2 | 86.29 Million TWD | 0.44% |
2013 Q1 | 93.45 Million TWD | -10.46% |
2013 Q3 | 83.72 Million TWD | -18.05% |
2013 Q4 | 78.83 Million TWD | -5.84% |
2013 FY | 358.18 Million TWD | -7.05% |
2013 Q2 | 102.16 Million TWD | 9.32% |
2012 FY | 385.35 Million TWD | 7.72% |
2012 Q4 | 104.37 Million TWD | 3.35% |
2012 Q3 | 100.99 Million TWD | 19.11% |
2012 Q2 | 84.78 Million TWD | -11.86% |
2012 Q1 | 96.2 Million TWD | 31.42% |
2011 Q1 | 92.91 Million TWD | -8.54% |
2011 FY | 357.75 Million TWD | -0.94% |
2011 Q4 | 73.2 Million TWD | -13.96% |
2011 Q3 | 85.08 Million TWD | -20.16% |
2011 Q2 | 106.55 Million TWD | 14.68% |
2010 Q1 | 82.29 Million TWD | 0.0% |
2010 FY | 361.14 Million TWD | 19.94% |
2010 Q2 | 84.64 Million TWD | 2.86% |
2010 Q4 | 101.59 Million TWD | 9.7% |
2010 Q3 | 92.61 Million TWD | 9.41% |
2009 FY | 301.09 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
St.Shine Optical Co.,Ltd. | 605.69 Million TWD | 17.779% |
Bioteque Corporation | 580.17 Million TWD | 14.162% |
Chi Sheng Pharma & Biotech Co., Ltd | 61.21 Million TWD | -713.562% |
Sunder Biomedical Tech. Co., Ltd. | -28.05 Million TWD | 1875.324% |
BenQ Medical Technology Corporation | 365.43 Million TWD | -36.279% |
Unicon Optical Co., Ltd. | -117.03 Million TWD | 525.529% |
Formosa Optical Technology Co.,Ltd. | 328.02 Million TWD | -51.822% |
Medeon Biodesign, Inc. | -839.56 Million TWD | 159.318% |
Concord Medical Co., Ltd. | 54.91 Million TWD | -806.882% |
Crystalvue Medical Corporation | 117.67 Million TWD | -323.201% |
Perfect Medical Industry Co., Ltd. | 58.37 Million TWD | -753.173% |
ICARES Medicus, Inc. | 118.64 Million TWD | -319.758% |
Lagis Enterprise Co., Ltd. | 77.1 Million TWD | -545.924% |
Amed Co., Ltd. | 123.28 Million TWD | -303.953% |